APO RESEARCH · REPORT
Dronabinol
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Product & engineering
Understand the product.
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Selected research
Market Structure
Global Dronabinol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Global key players of Dronabinol include Canopy Growth, Noramco, THC Pharm, Echo Pharmaceuticals, BOL Pharma and Aphios Corporation, etc. Top five players occupy for a share about 44%. North America is the largest market, with a share about 58%, followed by Europe and Asia-Pacific. In terms of product, Synthetic Dronabinol is the largest segment, with a share over 86%. In terms of application, Capsule is the largest market, with a share over 66%.
This report provides an overview of the global Dronabinol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Dronabinol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Dronabinol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dronabinol market size, projected growth trends, production technologies, key applications, and end-use industries.
Dronabinol Segment by Company
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing
Dronabinol Segment by Type
Synthetic Dronabinol
Natural Dronabinol
Dronabinol Segment by Application
Capsule
Oral Liquid
Dronabinol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dronabinol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dronabinol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dronabinol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dronabinol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dronabinol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dronabinol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dronabinol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic Dronabinol
- Natural Dronabinol
Applications
- Capsule
- Oral Liquid
Companies covered
- Canopy Growth
- Noramco
- KinetoChem
- Entourage Phytolab
- THC Pharm
- Echo Pharmaceuticals
- BOL Pharma
- Aphios Corporation
- Benuvia Manufacturing
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Dronabinol Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Dronabinol Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Dronabinol Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Dronabinol Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Dronabinol Market Dynamics
- 2.1 Dronabinol Industry Trends
- 2.2 Dronabinol Industry Drivers
- 2.3 Dronabinol Industry Opportunities and Challenges
- 2.4 Dronabinol Industry Restraints
3 Dronabinol Market by Manufacturers
- 3.1 Global Dronabinol Revenue by Manufacturers (2021-2026)
- 3.2 Global Dronabinol Sales by Manufacturers (2021-2026)
- 3.3 Global Dronabinol Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Dronabinol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dronabinol Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Dronabinol Manufacturers, Product Type & Application
- 3.7 Global Dronabinol Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dronabinol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dronabinol Players Market Share by Revenue in 2025
- 3.8.3 2025 Dronabinol Tier 1, Tier 2, and Tier 3
4 Dronabinol Market by Type
- 4.1 Dronabinol Type Introduction
- 4.1.1 Synthetic Dronabinol
- 4.1.2 Natural Dronabinol
- 4.2 Global Dronabinol Sales by Type
- 4.2.1 Global Dronabinol Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Dronabinol Sales by Type (2021-2032)
- 4.2.3 Global Dronabinol Sales Market Share by Type (2021-2032)
- 4.3 Global Dronabinol Revenue by Type
- 4.3.1 Global Dronabinol Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Dronabinol Revenue by Type (2021-2032)
- 4.3.3 Global Dronabinol Revenue Market Share by Type (2021-2032)
5 Dronabinol Market by Application
- 5.1 Dronabinol Application Introduction
- 5.1.1 Capsule
- 5.1.2 Oral Liquid
- 5.2 Global Dronabinol Sales by Application
- 5.2.1 Global Dronabinol Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Dronabinol Sales by Application (2021-2032)
- 5.2.3 Global Dronabinol Sales Market Share by Application (2021-2032)
- 5.3 Global Dronabinol Revenue by Application
- 5.3.1 Global Dronabinol Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Dronabinol Revenue by Application (2021-2032)
- 5.3.3 Global Dronabinol Revenue Market Share by Application (2021-2032)
6 Global Dronabinol Sales by Region
- 6.1 Global Dronabinol Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Dronabinol Sales by Region (2021-2032)
- 6.2.1 Global Dronabinol Sales by Region (2021-2026)
- 6.2.2 Global Dronabinol Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Dronabinol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Dronabinol Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Dronabinol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Dronabinol Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Dronabinol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Dronabinol Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Dronabinol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Dronabinol Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Dronabinol Revenue by Region
- 7.1 Global Dronabinol Revenue by Region
- 7.1.1 Global Dronabinol Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Dronabinol Revenue by Region (2021-2026)
- 7.1.3 Global Dronabinol Revenue by Region (2027-2032)
- 7.1.4 Global Dronabinol Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Dronabinol Revenue (2021-2032)
- 7.2.2 North America Dronabinol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Dronabinol Revenue (2021-2032)
- 7.3.2 Europe Dronabinol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Dronabinol Revenue (2021-2032)
- 7.4.2 Asia-Pacific Dronabinol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Dronabinol Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Dronabinol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Canopy Growth
- 8.1.1 Canopy Growth Company Information
- 8.1.2 Canopy Growth Business Overview
- 8.1.3 Canopy Growth Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Canopy Growth Dronabinol Product Portfolio
- 8.1.5 Canopy Growth Recent Developments
- 8.2 Noramco
- 8.2.1 Noramco Company Information
- 8.2.2 Noramco Business Overview
- 8.2.3 Noramco Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Noramco Dronabinol Product Portfolio
- 8.2.5 Noramco Recent Developments
- 8.3 KinetoChem
- 8.3.1 KinetoChem Company Information
- 8.3.2 KinetoChem Business Overview
- 8.3.3 KinetoChem Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 KinetoChem Dronabinol Product Portfolio
- 8.3.5 KinetoChem Recent Developments
- 8.4 Entourage Phytolab
- 8.4.1 Entourage Phytolab Company Information
- 8.4.2 Entourage Phytolab Business Overview
- 8.4.3 Entourage Phytolab Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Entourage Phytolab Dronabinol Product Portfolio
- 8.4.5 Entourage Phytolab Recent Developments
- 8.5 THC Pharm
- 8.5.1 THC Pharm Company Information
- 8.5.2 THC Pharm Business Overview
- 8.5.3 THC Pharm Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 THC Pharm Dronabinol Product Portfolio
- 8.5.5 THC Pharm Recent Developments
- 8.6 Echo Pharmaceuticals
- 8.6.1 Echo Pharmaceuticals Company Information
- 8.6.2 Echo Pharmaceuticals Business Overview
- 8.6.3 Echo Pharmaceuticals Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Echo Pharmaceuticals Dronabinol Product Portfolio
- 8.6.5 Echo Pharmaceuticals Recent Developments
- 8.7 BOL Pharma
- 8.7.1 BOL Pharma Company Information
- 8.7.2 BOL Pharma Business Overview
- 8.7.3 BOL Pharma Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 BOL Pharma Dronabinol Product Portfolio
- 8.7.5 BOL Pharma Recent Developments
- 8.8 Aphios Corporation
- 8.8.1 Aphios Corporation Company Information
- 8.8.2 Aphios Corporation Business Overview
- 8.8.3 Aphios Corporation Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Aphios Corporation Dronabinol Product Portfolio
- 8.8.5 Aphios Corporation Recent Developments
- 8.9 Benuvia Manufacturing
- 8.9.1 Benuvia Manufacturing Company Information
- 8.9.2 Benuvia Manufacturing Business Overview
- 8.9.3 Benuvia Manufacturing Dronabinol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Benuvia Manufacturing Dronabinol Product Portfolio
- 8.9.5 Benuvia Manufacturing Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Dronabinol Value Chain Analysis
- 9.1.1 Dronabinol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dronabinol Production Mode & Process
- 9.2 Dronabinol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dronabinol Distributors
- 9.2.3 Dronabinol Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst